-+ 0.00%
-+ 0.00%
-+ 0.00%

GRIFOLS ANNOUNCES LAST PATIENT LAST VISIT IN SPARTA, ITS PHASE 3 OUTCOMES STUDY OF PROLASTIN®-C IN PATIENTS WITH EMPHYSEMA DUE TO ALPHA-1 ANTITRYPSIN DEFICIENCY

Reuters·08/10/2026 11:00:02

Please log in to view news